CAC
Cowen and Company Portfolio holdings
AUM
$2.9B
This Quarter Return
+17.91%
1 Year Return
+104.28%
3 Year Return
+119.87%
5 Year Return
+632.2%
10 Year Return
–
AUM
$1.08B
AUM Growth
+$1.08B
(+91%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
41.34%
Top 10 Holdings %
Top 10 Hldgs %
72.09%
Holding
482
New
145
Increased
29
Reduced
40
Closed
183
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$114M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$113M |
| 3 |
Invesco QQQ Trust
QQQ
|
$73.3M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$72.9M |
| 5 |
iShares Russell 2000 ETF
IWM
|
$55.7M |
Top Sells
| 1 |
NKLA
Nikola Corporation Common Stock
NKLA
|
$40M |
| 2 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$20M |
| 3 |
AvePoint
AVPT
|
$14.5M |
| 4 |
McDonald's
MCD
|
$10.1M |
| 5 |
CMRC
Commerce.com, Inc. Series 1 Common Stock
CMRC
|
$5.84M |
Sector Composition
| 1 | Financials | 9.21% |
| 2 | Healthcare | 5.11% |
| 3 | Technology | 4.2% |
| 4 | Communication Services | 3.53% |
| 5 | Industrials | 2.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Ultragenyx Pharmaceutical
RARE
$3.04B
| – | – |
0
| – | – |
|
477
Vicarious Surgical
RBOT
$34.8M
| – | – |
-137,066
| Closed | -$1.34M |
|
478
Regions Financial
RF
$24B
| – | – |
-6,057
| Closed | -$70K |
|
479
Rigel Pharmaceuticals
RIGL
$710M
| – | – |
0
| – | – |
|
480
Invesco S&P 500 Pure Value ETF
RPV
$1.35B
| – | – |
-51,000
| Closed | -$2.5M |
|
481
Rush Street Interactive
RSI
$2.03B
| – | – |
-15,000
| Closed | -$191K |
|
482
Reviva Pharmaceuticals
RVPH
$31.3M
| – | – |
-24,600
| Closed | -$264K |
|